An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Ketamine therapy cost: Spravato, IV clinics and at-home programs

Spravato (esketamine), the FDA-approved ketamine-type nasal spray for depression, listed at $882 to $1,319 per treatment session in cash on Oct 25 2026, for the drug alone and before the clinic's observation fee [1].

Off-label IV ketamine cost $651 per infusion at one hospital program that publishes its price [2], and an at-home telehealth program listed $165 to $215 a session for new clients [3]. Ketamine itself is FDA approved only as an anesthetic, not for any psychiatric disorder [4].

Ketamine therapy is the use of ketamine or its close relative esketamine to treat depression and other psychiatric conditions; only esketamine nasal spray (Spravato) is FDA approved for depression.

At a glance

IV ketamine infusion
$651Per infusion, self-pay only, at one hospital program; Oct 25 2026 [2]
At-home ketamine
$165 to $215A session for new clients, $1,290 to $2,970 a program; Oct 25 2026 [3]
FDA status
Only SpravatoSpravato is approved with a REMS; ketamine only for anesthesia [4] [6]

If you are in crisis

Call or text 988, or chat at chat.988lifeline.org, to reach the 988 Suicide and Crisis Lifeline. It is free, confidential and open 24/7 [7]. If you or someone else is in immediate danger, call 911.

What ketamine therapy costs, by type

Ketamine therapy cash prices, checked Oct 25 2026
TypePriceWhat is includedCheckedSource
Spravato (esketamine nasal spray), cash$882.23 to $1,319.41 per sessionThe drug only, by kit size; the REMS-enrolled clinic bills the 2-hour observation visit separatelyOct 25 2026[1]
Spravato with commercial insurance and the maker's savings programAs little as $10 per treatment for the medicineMedicine cost only; does not cover observation; not for Medicare, Medicaid, TRICARE or VAOct 25 2026[5]
IV ketamine infusion, Boulder Community Health$651 per infusionInfusion sold through MDsave vouchers; psychiatric visits may be billed to insuranceOct 25 2026[2]
At-home ketamine, Mindbloom, 6 sessions$1,290 ($215 a session)Medicine, two clinician consults, three guide sessionsOct 25 2026[3]
At-home ketamine, Mindbloom, 18 sessions$2,970 ($165 a session)More guide and clinician timeOct 25 2026[3]
Spravato cash prices are Drugs.com figures for cash-paying customers, not valid with insurance [1]. IV and at-home ketamine are off-label uses of a drug FDA approved only for anesthesia [4].

These are per-session prices, and none of these treatments is a single visit. Ask any clinic how many sessions it plans in the first month and after, and get the total in writing. We do not give doses or session schedules on this page.

Spravato: the FDA-approved option

Spravato is esketamine nasal spray. Its label covers two uses in adults: treatment-resistant depression, alone or with an oral antidepressant, and depressive symptoms in major depressive disorder with acute suicidal thoughts or behavior, given with an oral antidepressant [6].

It is available only through a restricted program called a REMS. It is dispensed and given only in healthcare settings enrolled in the REMS, a clinician must watch you for at least 2 hours after each dose, and you must not drive or operate machinery until the next day after a restful sleep [6]. That observation time is why the clinic bills for more than the drug.

Spravato and insurance

  • Commercial plans. Aetna, for example, covers Spravato for treatment-resistant depression when the patient has had an inadequate response to two antidepressants from at least two different classes, each for at least 8 weeks, plus an augmentation trial or psychotherapy. It must be prescribed by or with a psychiatrist and given under direct supervision with 2 hours of monitoring [8]. Other plans set their own rules, so ask yours about prior authorization.
  • The maker's savings program. Spravato withMe lets people with commercial insurance pay as little as $10 per treatment for the medicine. It has an annual maximum, it does not cover the observation visit, and it is not open to people on Medicare, Medicaid, TRICARE, the Department of Defense or VA [5].
  • Medicare. Medicare contractor CGS tells clinics to bill Spravato sessions under codes G2082 and G2083, which include the drug and 2 hours of observation, with a modifier showing REMS enrollment [9]. Ask the clinic what your Part B share will be.

IV ketamine clinics: off-label and mostly self-pay

FDA has approved ketamine only as an injection for general anesthesia. In its 2023 warning, FDA said plainly: "Ketamine is not FDA approved for the treatment of any psychiatric disorder" [4]. Clinics that give IV ketamine for depression are using it off-label.

That shapes the bill. Boulder Community Health charges $651 per infusion through self-pay vouchers and does not bill insurance for the infusion [2]. University of Utah Health says ketamine infusions are not covered by insurance and must be paid before the infusion [10]. Aetna's policy calls ketamine experimental, investigational or unproven for depression by every route it lists, including IV [11].

At-home ketamine through telehealth

Mindbloom, one telehealth company, offers ketamine tablets or injections for use at home, at the same price either way [3]. It listed $1,290 for 6 sessions, $2,220 for 12 and $2,970 for 18 for new clients, and said it does not accept insurance, though it gives a superbill you can send to your plan [3]. It says it is available in 38 states [14]. Read our Mindbloom review for its record, including a wrongful death lawsuit filed in October 2025 whose claims are allegations; we found no ruling as of Oct 25 2026 [15].

FDA's 2023 warning on compounded and at-home ketamine

On Oct 10 2023 FDA warned patients and providers about compounded ketamine, including oral forms, for psychiatric disorders. Compounded products are not FDA reviewed for safety, effectiveness or quality, and FDA has not set a safe or effective dose for any psychiatric use. FDA named risks including sedation, dissociation, abuse and misuse, psychiatric events, higher blood pressure, slowed breathing and bladder problems, and said home use adds risk because no provider is there to watch for problems. It described a patient whose breathing slowed after taking compounded oral ketamine at home. Unlike Spravato, compounded ketamine has no REMS [4].

We earn commissions from some partners, which can affect where they appear on this page. It never changes a verdict. How we make money

At-home ketamine program we have reviewed (Clean)

  1. Mindbloom

    Clean

    Good fit for: an at-home ketamine program with guide sessions

    Price$1,290 for 6 sessions to $2,970 for 18, or $165 to $215 a session (checked Oct 25 2026) [3]
    What you get
    Compounded ketamine tablets or injections taken at home, with guide sessions [3]
    FDA record
    No warning letter to the company found [13]; see FDA's 2023 ketamine alert [4]
    BBB
    A, not accredited [12]
    Note
    No insurance; superbill provided [3]

    Visit Mindbloomon the Mindbloom website

Safety warnings to know before any session

Spravato carries a boxed warning for sedation, dissociation, slowed breathing, abuse and misuse, and suicidal thoughts and behaviors in young people taking antidepressants [6]. Its label also says:

  • Who should not use it. People with aneurysmal blood vessel disease or an arteriovenous malformation, a history of bleeding in the brain, or an allergy to esketamine or ketamine [6].
  • Blood pressure. It can raise blood pressure significantly, so the clinic checks it after each dose [6].
  • Thinking and driving. It briefly affects attention and performance; no driving until the next day after a restful sleep [6].
  • Pregnancy. It may cause fetal harm and is not recommended during pregnancy [6].
  • Common side effects. Dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, higher blood pressure, vomiting and feeling drunk [6].

FDA's 2023 warning lists the same kinds of risks for ketamine used outside these controls [4]. Report side effects from compounded ketamine to FDA's MedWatch program [4].

Hidden costs

  • Observation and visit fees. Spravato's cash drug price does not include the clinic's 2-hour observation visit [1] [5].
  • Psychiatric visits. Aetna requires a psychiatrist to prescribe or consult for Spravato [8]. Boulder Community Health bills psychiatric consultations apart from the $651 infusion, possibly to insurance [2].
  • A ride home. No driving after Spravato until the next day after sleep, so plan transport [6].
  • Repeat sessions. Prices on this page are per session or per program; ask how many sessions are planned and what follow-up costs.

How to choose safely

  1. Start with your own doctor or psychiatrist. A concierge or private doctor can help coordinate care if you pay cash.
  2. If you have depression that has not responded to two antidepressants, ask whether Spravato is an option and whether your plan covers it [8].
  3. For any clinic, ask who monitors you, for how long, and what happens if your blood pressure or breathing changes [4] [6].
  4. Be wary of programs that skip in-person monitoring. FDA says home use adds risk [4].

If a clinic also offers wellness drips such as NAD+ or B12, compare those on our wellness injections page. Some peptides, such as Selank, are marketed for anxiety without FDA approval. How we choose what to cover is on our editorial standards page.

Questions people ask

How much does ketamine therapy cost?

On Oct 25 2026, Spravato's drug cost $882 to $1,319 per session in cash [1], one hospital charged $651 per IV ketamine infusion [2], and an at-home program listed $165 to $215 a session for new clients [3].

How much does Spravato cost?

Drugs.com listed Spravato at $882.23 to $1,319.41 per treatment session for cash-paying customers on Oct 25 2026, depending on kit size, before the clinic's observation fee [1]. With commercial insurance, the maker's program can cut the medicine cost to as little as $10 per treatment [5].

Does insurance cover Spravato?

Coverage depends on your plan. Aetna, for example, covers it for treatment-resistant depression after an inadequate response to two antidepressants from different classes, prescribed by or with a psychiatrist [8]. Medicare contractor CGS lists billing codes G2082 and G2083 for Spravato sessions [9].

Does insurance cover IV ketamine for depression?

Usually not. University of Utah Health says ketamine infusions are not covered by insurance [10], and Aetna considers ketamine, including IV, experimental for depression [11]. Boulder Community Health sells infusions at $651 self-pay [2].

Is ketamine FDA approved for depression?

No. FDA says ketamine is not approved for any psychiatric disorder; it is approved as an injection for anesthesia [4]. Esketamine nasal spray (Spravato) is approved for treatment-resistant depression and for depressive symptoms with acute suicidal thoughts, with an oral antidepressant [6].

Is at-home ketamine safe?

FDA warned on Oct 10 2023 that compounded ketamine, including oral forms used at home, has not been reviewed for safety or effectiveness and that home use adds risk because no provider is there to monitor for problems such as slowed breathing [4].

Why does Spravato have to be given in a clinic?

Spravato is available only through a REMS: it is given in healthcare settings enrolled in the REMS, a clinician watches you for at least 2 hours after each dose, and you may not drive until the next day after a restful sleep [6].

Where can I get help right now?

Call or text 988, or chat at chat.988lifeline.org, to reach the 988 Suicide and Crisis Lifeline. It is free, confidential and available 24/7 [7]. If someone is in immediate danger, call 911.

Medical review: pending. A licensed clinician has not yet reviewed this page.

Sources

15 cited
  1. Spravato prices. Drugs.com, accessed 2026-10-25.
  2. Ketamine FAQs, Center for Interventional Psychiatry. Boulder Community Health, accessed 2026-10-25.
  3. Mindbloom pricing. Mindbloom, accessed 2026-10-25.
  4. FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders. US Food and Drug Administration, 2023-10-10 (accessed 2026-10-25).
  5. Spravato withMe Savings Program requirements. Johnson & Johnson, 2025-10 (accessed 2026-10-25).
  6. Spravato (esketamine) nasal spray prescribing information. DailyMed, National Library of Medicine, revised 2026-03 (accessed 2026-10-25).
  7. 988 Suicide and Crisis Lifeline. 988 Lifeline, accessed 2026-10-25.
  8. Esketamine (Spravato), clinical policy bulletin 0950. Aetna, reviewed 2026-02-25 (accessed 2026-10-25).
  9. Billing esketamine (Spravato) nasal spray. CGS Medicare Part B, 2023-05-01, revised 2023-12-21 (accessed 2026-10-25).
  10. Ketamine infusion, Huntsman Mental Health Institute. University of Utah Health, accessed 2026-10-25.
  11. Ketamine for the treatment of depression and other psychiatric disorders, clinical policy bulletin 0938. Aetna, reviewed 2025-12-30 (accessed 2026-10-25).
  12. Mindbloom BBB business profile. Better Business Bureau, Oct 25, 2026.
  13. Warning letters database. U.S. Food and Drug Administration, Oct 25, 2026.
  14. At-home ketamine therapy by state. Mindbloom, Oct 25, 2026.
  15. Wrongful death lawsuit filed in ketamine overdose of Greenville man. WITN, 2025-10-22 (accessed 2026-10-25).

This page is general information, not medical advice. Talk with a licensed clinician about your own care.